Enhanced nanoparticle uptake into virus infected cells: could nanoparticles be useful in antiviral therapy?

Abo-zeid, Yasmin; Urbanowicz, Richard A.; Thomson, Brian J.; Irving, William L.; Tarr, Alexander W.; Garnett, Martin C.

doi:10.1016/j.ijpharm.2018.06.027

All Outputs (3)

Functional and immunogenic characterization of diverse HCV glycoprotein E2 variants (2018)
Journal Article

© 2018 European Association for the Study of the Liver Background & Aims: Induction of cross-reactive antibodies targeting conserved epitopes of the envelope proteins E1E2 is a key requirement for an hepatitis C virus vaccine. Conserved epitopes like... Read More about Functional and immunogenic characterization of diverse HCV glycoprotein E2 variants.

Immunization with a synthetic consensus hepatitis C virus E2 glycoprotein ectodomain elicits virus-neutralizing antibodies (2018)
Journal Article

Global eradication of hepatitis C virus (HCV) infection will require an efficacious vaccine capable of eliciting protective immunity against genetically diverse HCV strains. Natural spontaneous resolution of HCV infection is associated with productio... Read More about Immunization with a synthetic consensus hepatitis C virus E2 glycoprotein ectodomain elicits virus-neutralizing antibodies.

Enhanced nanoparticle uptake into virus infected cells: could nanoparticles be useful in antiviral therapy? (2018)
Journal Article

Virus infections cause diseases of different severity ranged from mild infection e.g. common cold into life threatening diseases e.g. Human Immunodeficiency virus (HIV), Hepatitis B. Virus infections represent 44% of newly emerging infections. Althou... Read More about Enhanced nanoparticle uptake into virus infected cells: could nanoparticles be useful in antiviral therapy?.